Oral GnRH antagonist (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oral GnRH antagonist (investigational), covering 2025-03-18 to 2025-03-18. Get the full timeline:
Most recent: Clinical Trial Update: An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women [Phase 4]